Results 231 to 240 of about 121,678 (291)

Using Machine Learning to Predict the Prognosis in Endometrial Cancer Patients Undergoing Fertility‐Sparing Treatment

open access: yesCancer Medicine, Volume 14, Issue 22, November 2025.
ABSTRACT Background Endometrial cancer is a significant gynecological malignancy with rising incidence among women of reproductive age, necessitating effective fertility‐sparing treatments. Machine learning offers potential in enhancing prognostic assessments through radiomics.
Wenhan Yuan   +3 more
wiley   +1 more source

Bee‐Derived Antioxidants as a Protective Strategy Against Doxorubicin‐Induced Ovarian Damage

open access: yesChemistry &Biodiversity, Volume 22, Issue 11, November 2025.
Graphical abstract of Bee‐Derived Antioxidants as a Protective Strategy Against Doxorubicin‐Induced Ovarian Damage ABSTRACT Antineoplastic agents can induce tissue damage through oxidative stress mechanisms. Doxorubicin, a widely used chemotherapeutic agent, has been shown to cause permanent damage to reproductive tissues.
Meltem Arıkan Malkoc   +3 more
wiley   +1 more source

Surgical Management of Ovarian Masses in Children: A Comparative Analysis by Pediatric Surgeons and Gynecologists at Two Academic Hospitals in Johannesburg

open access: yesCancer Reports, Volume 8, Issue 11, November 2025.
ABSTRACT Background and Objectives Existing literature on ovarian masses necessitating intervention in children by pediatric surgeons and gynecologists in Low‐ and Middle‐Income Countries is sparse and lacks collaborative standardization in management between the two subspecialties.
Nkhensani C. Mashaba   +4 more
wiley   +1 more source

Validation of the Finnish Diabetes Risk Score (FINDRISC) in a Central‐European Population for the Prediction of Cumulative Incidence of Type 2 Diabetes Over 8‐Years—Follow‐Up of the Budakalász Health Examination Survey (BHES)

open access: yesDiabetes/Metabolism Research and Reviews, Volume 41, Issue 8, November 2025.
ABSTRACT Aims FINDRISC is widely used to assess 10‐year incidence of drug‐treated type 2 diabetes; however, it may require recalibration before implementation in new populations. Thus, we investigated the performance of FINDRISC and recalibrated it in the Hungarian population.
Zsolt Bagyura   +7 more
wiley   +1 more source

Adverse Cardiometabolic Outcomes in Men With Sisters With Polycystic Ovary Syndrome.

open access: yesJ Clin Endocrinol Metab
Kanina A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy